Machine Learning-Based Drug Repositioning of Novel Human Aromatase Inhibitors Utilizing Molecular Docking and Molecular Dynamic Simulation
Authors:
- Damilola Samuel BodunDBDamilola Samuel Bodun
- Adeniyi Ayinde AbdulwahabAAAdeniyi Ayinde Abdulwahab
- Temitope Ibukunoluwa AdegbenroTATemitope Ibukunoluwa Adegbenro
- Samuel Aduramurewa OsunnayaSOSamuel Aduramurewa Osunnaya
- Mary Oluwatominsin AlongeMAMary Oluwatominsin Alonge
- Zainab Olaide DiyaoluZDZainab Olaide Diyaolu
- Muhammad Temitope AbdulazeezMAMuhammad Temitope Abdulazeez
- Rachael Oluwakamiye AboladeRARachael Oluwakamiye Abolade
- 19 December 2024
- journal article
- research article
- Published by World Scientific Pub Co Pte Ltd in Journal of Computational Biophysics and Chemistry
- Vol. 24 (03) , 371-387
Abstract
In the continuous search for potential drug-like molecules for diseases, drug repurposing offers a solution by identifying new roles for the existing drugs. For breast cancer, which is the leading cause of death among women, discovering a new drug with fewer side effects can take more than a year, and drug repurposing provides a faster alternative. In this study, we used machine learning (ML) and structure-based screening to evaluate molecules from the ChEMBL library against Human Aromatase, an enzyme that is involved in the conversion of androgens to estrogen. The virtual screening output identified 148 potential compounds. These compounds were further subjected to detailed structure-based virtual screening, followed by assessment of induced fit docking, quantum-based docking and ADMET properties. The top compound, CHEMBL502014 and the co-crystallized ligand (reference) were evaluated through MD simulations for 100 ns. The results indicated that the CHEMBL502014-Aromatase complex demonstrated better conformational stability throughout the simulation compared to the reference ligand. Based on these analyses, we propose CHEMBL502014 and other top compounds with known activities against various proteins as potential candidates for anti-cancer activity against breast cancer. These compounds should be further evaluated using experimental assays to confirm their effectiveness against breast cancer.Keywords
This publication has 33 references indexed in Scilit:
- Machine Learning-Based Drug Repositioning of Novel Janus Kinase 2 Inhibitors Utilizing Molecular Docking and Molecular Dynamic SimulationJournal of Chemical Information and Modeling, 2023
- Virtual screening and library enumeration of new hydroxycinnamates based antioxidant compounds: A complete frameworkJournal of Saudi Chemical Society, 2023
- QSAR-based virtual screening of traditional Chinese medicine for the identification of mitotic kinesin Eg5 inhibitorsComputational Biology and Chemistry, 2023
- Virtual screening of efficient building blocks and designing of new polymers for organic solar cellsJournal of Physics and Chemistry of Solids, 2023
- Identification of Phyto-Compounds from Ilex kudingcha as Inhibitors of Sterol-14α-Demethylase Protease: A Computational Approach Against Chagas DiseaseChemistry Africa, 2022
- Aromatase inhibitors: Role in postmenopausal breast cancerArchiv der Pharmazie, 2020
- Integrating Molecular Docking and Molecular Dynamics Simulations2019
- Exploring the chemical space of aromatase inhibitorsMolecular Diversity, 2013
- Suppression of estrogen actions in human lung cancerMolecular and Cellular Endocrinology, 2011
- Aromatase, aromatase inhibitors, and breast cancerThe Journal of Steroid Biochemistry and Molecular Biology, 2011